Funds · PRLD

Who owns PRLD?

Institutional ownership of Prelude Therapeutics Incorporated from Form 13F, Q2 2026

75 institutional managers reported holding Prelude Therapeutics Incorporated (PRLD) in Form 13F filings for Q2 2026, with 49,599,407 shares worth $264M. The largest reported holder was Orbimed Advisors LLC. Managers that filed both quarters added a net 18,827,564 shares (+61.2%). 34 opened new positions and 13 sold out.

Funds holding
75
Value held
$264M
New / sold out
34 / 13
Net shares, same filers
+61.2%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of PRLD

FundValueShare of 13F holdingsSharesMove
Orbimed Advisors LLC$73.2M27.7%13,724,571Added
Baker Bros. Advisors LP$54.0M20.4%10,123,824Unchanged
Ra Capital Management, L.p.$34.5M13.1%6,475,882New
Soleus Capital Management, L.P.$18.0M6.8%3,378,378New
Kynam Capital Management, LP$12.9M4.9%2,415,087Added
Vanguard Capital Management LLC$10.7M4.1%2,009,445Added
BlackRock, Inc.$9.6M3.6%1,797,501Added
Sphera Funds Management LTD.$5.4M2.1%1,019,832Added
Two Sigma Investments, LP$5.3M2.0%993,369Added
ADAR1 Capital Management, LLC$4.8M1.8%900,900Added
Millennium Management LLC$4.5M1.7%844,993Added
Geode Capital Management, LLC$4.5M1.7%841,862Added
Adage Capital Partners GP, L.l.c.$4.1M1.5%766,095New
Acadian Asset Management LLC$3.3M1.2%611,359Added
Morgan Stanley$2.7M1.0%503,860Added
State Street Corp$2.3M0.9%428,787Added
UBS Group AG$1.7M0.6%318,797Added
Vanguard Fiduciary Trust Co$1.5M0.6%284,886Added
Renaissance Technologies LLC$1.5M0.6%281,200Added
Northern Trust Corp$1.3M0.5%240,599Added
Vanguard Portfolio Management LLC$1.0M0.4%193,920New
Marshall Wace, LLP$1.0M0.4%190,692Trimmed
Connor, Clark & Lunn Investment Management Ltd.$669K0.3%125,606Added
Goldman Sachs Group Inc$644K0.2%120,834Trimmed
Hillsdale Investment Management Inc.$434K0.2%81,400New

Share of 13F holdings is each fund's shares as a share of the 49,599,407 PRLD shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $112M and sold $8.0M; 25 added and 8 trimmed.

Schedule 13D and 13G filings on PRLD

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about PRLD ownership

Who owns PRLD stock?
75 institutional investment managers reported PRLD positions in their Form 13F filings for Q2 2026, holding 49,599,407 shares worth $264M in total. Orbimed Advisors LLC reported the largest position.
Are funds buying or selling PRLD?
In Q2 2026, 34 managers opened new PRLD positions, 25 added, 8 trimmed and 13 sold out. Managers that filed in both quarters added a net 18,827,564 shares.
How current is this PRLD institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PRLD by CUSIP. Options are left out. PRLD news and filings · PRLD insider trades · Top funds